Central manipulation of dopamine receptors attenuates the orexigenic action of ghrelin

Psychopharmacology

Volumn 229, Issue 2, 2013, Pages 275-283

  Romero Picó, Amparo ^a,b   Novelle, Marta G ^a,b   Folgueira, Cintia ^a,b   López, Miguel ^a,b   Nogueiras, Ruben ^a,b   Diéguez, Carlos ^a,b  

^a University of Santiago de Compostela ^*  (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Appetite; Dopamine receptor; Food intake

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ACETYLATED HUMAN GHRELIN; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE RECEPTOR; ETICLOPRIDE; GHRELIN; QUINPIROLE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DOSE COMPARISON; DRUG POTENTIATION; FEEDING BEHAVIOR; FOOD INTAKE; LOCOMOTION; MALAISE; MALE; NONHUMAN; OREXIGENIC ACTION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; SIGNAL TRANSDUCTION; TASTE AVERSION;

ANALYSIS OF VARIANCE; ANIMALS; AVOIDANCE LEARNING; DOPAMINE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; DRUG INTERACTIONS; EATING; GHRELIN; INJECTIONS, INTRAVENTRICULAR; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE; TASTE; TIME FACTORS;

EID: 84883465771     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-013-3096-7     Document Type: Article

References (52)

1. Abizaid A, Liu ZW et al (2006) Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. J Clin Invest 116(12):3229-3239
2. Abizaid A, Mineur YS et al (2011) Reduced locomotor responses to cocaine in ghrelin-deficient mice. Neuroscience 192:500-506
3. Andrews ZB, Liu ZW et al (2008) UCP2 mediates ghrelin's action on NPY/AgRP neurons by lowering free radicals. Nature 454(7206):846-851
4. Baker RW, Osman J et al (2001) Differential actions of dopamine receptor antagonism in rats upon food intake elicited by either mercaptoacetate or exposure to a palatable high-fat diet. Pharmacol Biochem Behav 69(1-2):201-208
5. Barbano MF, Le Saux M et al (2009) Involvement of dopamine and opioids in the motivation to eat: influence of palatability, homeostatic state, and behavioral paradigms. Psychopharmacology (Berl) 203(3):475-487
6. Bourne JA (2001) SCH 23390: the first selective dopamine D1-like receptor antagonist. CNS Drug Rev 7(4):399-414
7. Carr KD, Tsimberg Y et al (2003) Evidence of increased dopamine receptor signaling in food-restricted rats. Neuroscience 119(4):1157-1167
8. Cummings DE, Frayo RS et al (2004) Plasma ghrelin levels and hunger scores in humans initiating meals voluntarily without time- and food-related cues. Am J Physiol Endocrinol Metab 287(2):E297-E304
9. Currie PJ, Khelemsky R et al (2012) Ghrelin is an orexigenic peptide and elicits anxiety-like behaviors following administration into discrete regions of the hypothalamus. Behav Brain Res 226(1):96-105
10. Davis C, Curtis C et al (2011) Evidence that 'food addiction' is a valid phenotype of obesity. Appetite 57(3):711-717
11. Fulton S, Pissios P et al (2006) Leptin regulation of the mesoaccumbens dopamine pathway. Neuron 51(6):811-822
12. Gilbert DB, Cooper SJ (1985) Analysis of dopamine D1 and D2 receptor involvement in d- and l-amphetamine-induced anorexia in rats. Brain Res Bull 15(4):385-389
13. Hommel JD, Trinko R et al (2006) Leptin receptor signaling in midbrain dopamine neurons regulates feeding. Neuron 51(6):801-810
14. Jacoby SM, Currie PJ (2011) SKF 83566 attenuates the effects of ghrelin on performance in the object location memory task. Neurosci Lett 504(3):316-320
15. Jerlhag E, Egecioglu E et al (2006) Ghrelin stimulates locomotor activity and accumbal dopamine-overflow via central cholinergic systems in mice: implications for its involvement in brain reward. Addict Biol 11(1):45-54
16. Jerlhag E, Egecioglu E et al (2007) Ghrelin administration into tegmental areas stimulates locomotor activity and increases extracellular concentration of dopamine in the nucleus accumbens. Addict Biol 12(1):6-16
17. Jiang H, Betancourt L et al (2006) Ghrelin amplifies dopamine signaling by cross talk involving formation of growth hormone secretagogue receptor/dopamine receptor subtype 1 heterodimers. Mol Endocrinol 20(8):1772-1785
18. Kern A, Albarran-Zeckler R et al (2012) Apo-ghrelin receptor forms heteromers with DRD2 in hypothalamic neurons and is essential for anorexigenic effects of DRD2 agonism. Neuron 73(2):317-332
19. Kola B, Farkas I et al (2008) The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system. PLoS One 3(3):e1797
20. Lage R, Vazquez MJ et al (2010) Ghrelin effects on neuropeptides in the rat hypothalamus depend on fatty acid metabolism actions on BSX but not on gender. FASEB J 24(8):2670-2679
21. Lanteri C, Salomon L et al (2008) Drugs of abuse specifically sensitize noradrenergic and serotonergic neurons via a non-dopaminergic mechanism. Neuropsychopharmacology 33(7):1724-1734
22. Lopez M, Lage R et al (2008) Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin. Cell Metab 7(5):389-399
23. Maldonado R, Valverde O et al (2006) Involvement of the endocannabinoid system in drug addiction. Trends Neurosci 29(4):225-232
24. Malik S, McGlone F et al (2008) Ghrelin modulates brain activity in areas that control appetitive behavior. Cell Metab 7(5):400-409
25. Martelle JL, Nader MA (2008) A review of the discovery, pharmacological characterization, and behavioral effects of the dopamine D2-like receptor antagonist eticlopride. CNS Neurosci Ther 14(3):248-262
26. Meguid MM, Fetissov SO et al (2000) Hypothalamic dopamine and serotonin in the regulation of food intake. Nutrition 16(10):843-857
27. Nakazato M, Murakami N et al (2001) A role for ghrelin in the central regulation of feeding. Nature 409(6817):194-198
28. Naleid AM, Grace MK et al (2005) Ghrelin induces feeding in the mesolimbic reward pathway between the ventral tegmental area and the nucleus accumbens. Peptides 26(11):2274-2279
29. Narayanan NS, Guarnieri DJ et al (2010) Metabolic hormones, dopamine circuits, and feeding. Front Neuroendocrinol 31(1):104-112
30. Nogueiras R, Lopez M et al (2008) Bsx, a novel hypothalamic factor linking feeding with locomotor activity, is regulated by energy availability. Endocrinology 149(6):3009-3015
31. Nogueiras R, Perez-Tilve D et al (2009) Direct control of peripheral lipid deposition by CNS GLP-1 receptor signaling is mediated by the sympathetic nervous system and blunted in diet-induced obesity. J Neurosci 29(18):5916-5925
32. Palmiter RD (2007) Is dopamine a physiologically relevant mediator of feeding behavior? Trends Neurosci 30(8):375-381
33. Patterson TA, Brot MD et al (1998) Food deprivation decreases mRNA and activity of the rat dopamine transporter. Neuroendocrinology 68(1):11-20
34. Pelletier G, Simard J (1991) Dopaminergic regulation of pre-proNPY mRNA levels in the rat arcuate nucleus. Neurosci Lett 127(1):96-98
35. Pothos EN, Hernandez L et al (1995) Chronic food deprivation decreases extracellular dopamine in the nucleus accumbens: implications for a possible neurochemical link between weight loss and drug abuse. Obes Res 3(Suppl 4):525S-529S
36. Rashid AJ, So CH et al (2007) D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum. Proc Natl Acad Sci U S A 104(2):654-659
37. Ritter S, Hutton B (1995) Mercaptoacetate-induced feeding is impaired by central nucleus of the amygdala lesions. Physiol Behav 58(6):1215-1220
38. Sakkou M, Wiedmer P et al (2007) A role for brain-specific homeobox factor Bsx in the control of hyperphagia and locomotory behavior. Cell Metab 5(6):450-463
39. Schmid DA, Held K et al (2005) Ghrelin stimulates appetite, imagination of food, GH, ACTH, and cortisol, but does not affect leptin in normal controls. Neuropsychopharmacology 30(6):1187-1192
40. Seeman P, Van Tol HH (1994) Dopamine receptor pharmacology. Trends Pharmacol Sci 15(7):264-270
41. Seoane LM, Lopez M et al (2003) Agouti-related peptide, neuropeptide Y, and somatostatin-producing neurons are targets for ghrelin actions in the rat hypothalamus. Endocrinology 144(2):544-551
42. Skibicka KP, Dickson SL (2011) Ghrelin and food reward: the story of potential underlying substrates. Peptides 32(11):2265-2273
43. Sun Y, Ahmed S et al (2003) Deletion of ghrelin impairs neither growth nor appetite. Mol Cell Biol 23(22):7973-7981
44. Sun Y, Wang P et al (2004) Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc Natl Acad Sci U S A 101(13):4679-4684
45. Sutoo D, Akiyama K (1999) Effect of dopamine receptor anatagonists on the calcium-dependent central function that reduces blood pressure in spontaneously hypertensive rats. Neurosci Lett 269(3):133-136
46. Thanos PK, Michaelides M et al (2008) Food restriction markedly increases dopamine D2 receptor (D2R) in a rat model of obesity as assessed with in-vivo muPET imaging ([11C] raclopride) and in-vitro ([3H] spiperone) autoradiography. Synapse 62(1):50-61
47. Tschop M, Smiley DL et al (2000) Ghrelin induces adiposity in rodents. Nature 407(6806):908-913
48. Velasquez DA, Martinez G et al (2011) The central Sirtuin 1/p53 pathway is essential for the orexigenic action of ghrelin. Diabetes 60(4):1177-1185
49. Weinberg ZY, Nicholson ML et al (2011) 6-Hydroxydopamine lesions of the ventral tegmental area suppress ghrelin's ability to elicit food-reinforced behavior. Neurosci Lett 499(2):70-73
50. Wortley KE, Anderson KD et al (2004) Genetic deletion of ghrelin does not decrease food intake but influences metabolic fuel preference. Proc Natl Acad Sci U S A 101(21):8227-8232
51. Wren AM, Small CJ et al (2000) The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 141(11):4325-4328
52. Zigman JM, Nakano Y et al (2005) Mice lacking ghrelin receptors resist the development of diet-induced obesity. J Clin Invest 115(12):3564-3572